145 related articles for article (PubMed ID: 7865322)
1. Preparations for HIV vaccine efficacy trials. Vaccine selection guidelines. National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Barker LF
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S295-6. PubMed ID: 7865322
[No Abstract] [Full Text] [Related]
2. The role of prevention research in HIV vaccine trials.
Vermund SH
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S303-5. PubMed ID: 7865326
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in AIDS vaccine research and development.
Johnston MI; Noe JS; Killen JY
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S317-23. PubMed ID: 7865330
[TBL] [Abstract][Full Text] [Related]
4. National vaccine effort seen as insufficient.
AIDS Alert; 1998 Jan; 13(1):4-6. PubMed ID: 11364864
[TBL] [Abstract][Full Text] [Related]
5. Preparations for AIDS vaccine trials. Intellectual property issues related to AIDS vaccine development from a federal laboratory perspective.
Mays TD; Maurey K
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S301. PubMed ID: 7865325
[No Abstract] [Full Text] [Related]
6. Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines.
Robinson HL; Weinhold KJ
J Infect Dis; 2006 Dec; 194(12):1625-7. PubMed ID: 17109331
[No Abstract] [Full Text] [Related]
7. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
8. AIDSVAX. VaxGen.
Billich A
Curr Opin Investig Drugs; 2001 Sep; 2(9):1203-8. PubMed ID: 11717805
[TBL] [Abstract][Full Text] [Related]
9. New vaccine+HAART treatment trial enrolling at NIH. National Institutes of Health.
James JS
AIDS Treat News; 1998 Aug; (No 300):3-4. PubMed ID: 11365687
[TBL] [Abstract][Full Text] [Related]
10. Preparations for AIDS vaccine evaluations. AIDS International Training and Research Program.
Bridbord K
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S227-9. PubMed ID: 7865307
[No Abstract] [Full Text] [Related]
11. Vaccine trial needs subjects.
AIDS Patient Care STDS; 2002 May; 16(5):244. PubMed ID: 12058702
[No Abstract] [Full Text] [Related]
12. Human versus HIV: round 2 defeat in AIDS vaccine development.
Lu S
Expert Rev Vaccines; 2008 Mar; 7(2):151-3. PubMed ID: 18324884
[No Abstract] [Full Text] [Related]
13. Trial objectives and end points for measuring the efficacy of HIV vaccines.
Hoff R; Barker LF
Infect Agents Dis; 1995 Jun; 4(2):95-101. PubMed ID: 7613732
[TBL] [Abstract][Full Text] [Related]
14. Update on HIV vaccines.
Meldorf M; Corey L
STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929
[TBL] [Abstract][Full Text] [Related]
15. Why we don't need a relative risk standard for adolescent HIV vaccine trials in South Africa.
Slack CM
Am J Bioeth; 2011 Jun; 11(6):21-2. PubMed ID: 21678209
[No Abstract] [Full Text] [Related]
16. HIV vaccine research in Thailand: lessons learned.
Pitisuttithum P
Expert Rev Vaccines; 2008 Apr; 7(3):311-7. PubMed ID: 18393601
[TBL] [Abstract][Full Text] [Related]
17. Massachusetts university to begin human HIV vaccine trials.
AIDS Policy Law; 2004 Apr; 19(7):9. PubMed ID: 15124606
[No Abstract] [Full Text] [Related]
18. HIV vaccine efficacy trials: towards the future of HIV prevention.
Kim D; Elizaga M; Duerr A
Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
[TBL] [Abstract][Full Text] [Related]
19. Army HIV vaccine to undergo clinical trial as rival is halted.
Check E
Nature; 2002 Mar; 416(6876):6. PubMed ID: 11882860
[No Abstract] [Full Text] [Related]
20. Policy rebuttal. HIV vaccine trial justified.
McNeil JG; Johnston MI; Birx DL; Tramont EC
Science; 2004 Feb; 303(5660):961. PubMed ID: 14963313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
